News tagged with metastases
ASTRO develops brain metastases guideline
The American Society for Radiation Oncology (ASTRO) has developed a guideline on the radiotherapeutic and surgical management for newly diagnosed brain metastases. It has been published in Practical Radiation Oncology (PRO), ...
Feb 08, 2012 |
not rated yet |
0
Targeting tumors may help stop spread of breast, other cancers
(Medical Xpress) -- Cancer that has spread from the site of an original tumor to other places in the body is often viewed as a death sentence. But if there are just a few of those secondary tumors, called metastases, some ...
Feb 03, 2012 |
not rated yet |
0
New research confirms need for lung cancer testing
Different kinds of lung cancer behave in different ways, suggesting they are fundamentally different diseases. According to a University of Colorado Cancer Center study published in Cancer, the official journal of the Am ...
Feb 02, 2012 |
4.5 / 5 (2) |
0
|
Spread of nasopharyngeal carcinoma is reduced by bevacizumab, according to phase 2 trial results
The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.
Dec 16, 2011 |
not rated yet |
0
Nipping metastases in the bud: A novel strategy for fighting cancer targets secondary tumors
The proliferation of metastases is often the main cause of complications and death from cancer. For the first time, researchers are looking very closely at the development of these metastases themselves, instead ...
Dec 07, 2011 |
not rated yet |
0
|
Blood protein EPO involved in origin and spread of cancer
Researchers at the Swedish medical university Karolinska Institutet have demonstrated that a growth hormone, PDGF-BB, and the blood protein EPO are involved in the development of cancer tumours and that they combine to help ...
Dec 05, 2011 |
not rated yet |
1
|
What wakes dormant tumor cells
Prostate tumor cells can be lulled to sleep by a factor released by bone cells, according to a study published online this week in the Journal of Experimental Medicine. Disease recurs in up to half of prostate cancer patien ...
Nov 28, 2011 |
not rated yet |
0
P Rex-1 protein key to melanoma metastasis
Researchers from UNC Lineberger Comprehensive Cancer Center are part of a team that has identified a protein, called P-Rex1, that is key to the movement of cells called melanoblasts. When these cells experience uncontrolled ...
Nov 22, 2011 |
not rated yet |
0
Denosumab delays development of prostate cancer bone metastasis
An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer. The study, receiving Online First ...
Nov 16, 2011 |
not rated yet |
0
Uncovering a key player in metastasis
About 90 percent of cancer deaths are caused by secondary tumors, known as metastases, which spread from the original tumor site.
Nov 15, 2011 |
5 / 5 (4) |
1
|
More radionuclide therapy is better for prostate cancer patients
For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November ...
Nov 01, 2011 |
not rated yet |
0
Virtual fly-through bronchoscopy yields real results
For patients with non-small cell lung cancer (NSCLC) the accurate determination of the lymph node status before therapy is critical to develop an individualized treatment plan. Research from the October issue of the Journal of ...
Oct 03, 2011 |
not rated yet |
0
Bone-strengthening drug gives pain relief in prostate cancer bone metastases
Stockholm, Sweden: Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has ...
Sep 25, 2011 |
4 / 5 (1) |
0
New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
Stockholm, Sweden: Inhibiting a protein involved in bone metabolism can delay the onset of the bone metastases which are common in men with a particular form of prostate cancer, a researcher will tell the 2011 European Multidisciplinary ...
Sep 25, 2011 |
not rated yet |
0
Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients
Melanoma of the eye (ocular or uveal melanoma) frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients ...
Sep 23, 2011 |
4 / 5 (1) |
0
Metastasis
Metastasis, or metastatic disease (sometimes abbreviated mets), is the spread of a disease from one organ or part to another non-adjacent organ or part. It was previously thought that only malignant tumor cells and infections have the capacity to metastasize; however, this is being reconsidered due to new research. The word metastasis means "displacement" in Greek, from μετά, meta, "next", and στάσις, stasis, "placement". The plural is metastases.
Cancer occurs after a single cell in a tissue is progressively genetically damaged to produce a cancer stem cell possessing a malignant phenotype. These cancer stem cells are able to undergo uncontrolled abnormal mitosis, which serves to increase the total number of cancer cells at that location. When the area of cancer cells at the originating site becomes clinically detectable, it is called primary tumor. Some cancer cells also acquire the ability to penetrate and infiltrate surrounding normal tissues in the local area, forming a new tumor. The newly formed "daughter" tumor in the adjacent site within the tissue is called a local metastasis.
Some cancer cells acquire the ability to penetrate the walls of lymphatic and/or blood vessels, after which they are able to circulate through the bloodstream (circulating tumor cells) to other sites and tissues in the body. This process is known (respectively) as lymphatic or hematogeneous spread.
After the tumor cells come to rest at another site, they re-penetrate through the vessel or walls, continue to multiply, and eventually another clinically detectable tumor is formed. This new tumor is known as a metastatic (or secondary) tumor. Metastasis is one of three hallmarks of malignancy (contrast benign tumors). Most tumors and other neoplasms can metastasize, although in varying degrees (e.g. basal cell carcinoma rarely metastasize).
When tumor cells metastasize, the new tumor is called a secondary or metastatic tumor, and its cells are like those in the original tumor. This means, for example, that, if breast cancer metastasizes to the lungs, the secondary tumor is made up of abnormal breast cells, not of abnormal lung cells. The tumor in the lung is then called metastatic breast cancer, not lung cancer.
For more information about Metastasis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.